SDMHF OTC
Sartorius Stedim Biotech S.A.
1W: +0.4%
1M: +6.5%
3M: +13.8%
YTD: -0.8%
1Y: +23.5%
3Y: -2.5%
5Y: -60.2%
$244.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$8.0B
-2.9% ▼
5Y CAGR: +21.2%
Total Liabilities
$3.9B
-8.1% ▼
5Y CAGR: +19.6%
Shareholders Equity
$4.1B
+2.6% ▲
5Y CAGR: +22.9%
Cash & Investments
$426M
-38.2% ▼
5Y CAGR: +43.7%
Total Debt
$2.7B
-4.2% ▼
5Y CAGR: +36.2%
Net Debt
$2.3B
+6.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $224M | $107M | $117M | $679M | $426M |
| Short-Term Investments | $14M | $26M | $10M | $10M | $0 |
| Cash & ST Investments | $237M | $133M | $126M | $689M | $426M |
| Net Receivables | $0 | $405M | $0 | $267M | $227M |
| Inventory | $783M | $1.0B | $882M | $685M | $691M |
| Other Current Assets | $80M | $110M | $113M | $100M | $97M |
| Total Current Assets | $1.5B | $1.7B | $1.4B | $1.7B | $1.4B |
| Property, Plant & Equip. | $928M | $1.3B | $1.0B | $1.9B | $2.0B |
| Goodwill & Intangibles | $1.5B | $2.0B | $4.4B | $4.5B | $4.4B |
| Long-Term Investments | $1M | -$1M | $41M | $14M | $19M |
| Other Non-Current Assets | $14M | $28M | $868M | $14M | $3M |
| Total Non-Current Assets | $2.5B | $3.4B | $6.3B | $6.5B | $6.6B |
| Total Assets | $4.0B | $5.1B | $7.7B | $8.3B | $8.0B |
| — Liabilities — | |||||
| Accounts Payable | $251M | $252M | $258M | $310M | $278M |
| Short-Term Debt | $26M | $4M | $58M | $40M | $580M |
| Deferred Revenue | $660M | $663M | $186M | $0 | $168M |
| Other Current Liabilities | $580M | $686M | $224M | $441M | $205M |
| Total Current Liabilities | $1.0B | $1.0B | $937M | $939M | $1.4B |
| Long-Term Debt | $521M | $1.0B | $3.5B | $2.7B | $2.0B |
| Other Non-Current Liab. | $470M | $100K | $516M | $131M | -$99M |
| Total Non-Current Liabilities | $1.2B | $1.5B | $4.1B | $3.3B | $2.5B |
| Total Liabilities | $2.2B | $2.6B | $5.1B | $4.2B | $3.9B |
| — Equity — | |||||
| Common Stock | $18M | $18M | $18M | $20M | $19M |
| Retained Earnings | $1.4B | $2.2B | $2.4B | $2.5B | $2.7B |
| Accumulated OCI | $252M | $252M | $229M | $0 | $1.4B |
| Total Stockholders Equity | $1.7B | $2.4B | $2.6B | $4.0B | $4.1B |
| Total Liabilities & Equity | $4.0B | $5.1B | $7.7B | $8.3B | $8.0B |
| — Key Metrics — | |||||
| Total Debt | $626M | $1.1B | $3.7B | $2.9B | $2.7B |
| Net Debt | $402M | $1.0B | $3.6B | $2.2B | $2.3B |
| Total Investments | $15M | $25M | $41M | $24M | $19M |